Public Trust and the FDA: A Conversation with Regulatory Experts

Description

This panel will discuss ongoing challenges and questions surrounding FDA decision-making, authority, and trustworthiness. Discussion will include recent cases, including Alliance for Hippocratic Medicine v. FDA, about access to mifepristone, and litigation filed by state Attorneys General. 

Speakers will include: 

Tom Bollyky: Senior Fellow, Global Health, Economics, and Development and Director, Global Health Program, Council on Foreign Relations

Aaron Kesselheim, M.D.: Professor of Medicine Harvard Medical School; Visiting Professor of Law, Solomon Center for Health Law and Policy, Yale Law School

Reshma Ramachandran, M.D.: Assistant Professor of Medicine and Co-Director of the Yale Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT), Yale School of Medicine  

Joshua Sharfstein, M.D.: Vice Dean for Public Health Practice and Community Engagement and Professor of the Practice, Johns Hopkins Bloomberg School of Public Health

Zoom option available: Register here

Non-pizza lunch will be provided. 

Sponsoring Organization(s)

The Solomon Center for Health Law and Policy, Yale Health Law and Policy Society (YHeLPS)